Seven tumors were sporadic with unknown mutations, whereas the remainder were familial cancers, in which one of the known genes associated with breast cancer was mutated: BRCA1 (7 patients) or BRCA2 (8 patients). The gene discussed is BRCA2; the disease is hereditary cancer.